共 24 条
- [21] MODIFIED CHEMOTHERAPY WITH CARMUSTINE, CYTARABINE, CYCLO-PHOSPHAMIDE, AND 6-THIOGUANINE (BACT) AND AUTOLOGOUS BONE-MARROW TRANSPLANTION IN 24 POOR-RISK PATIENTS WITH ACUTE LYMPHOBLASTIC-LEUKEMIAJOURNAL OF THE NATIONAL CANCER INSTITUTE, 1986, 76 (06) : 1289 - 1293PICO, JLHARTMANN, OMARANINCHI, DBEAUJEAN, FBENHAMOU, EMASCRET, BNOVAKOVITCH, GGHALIE, RKALIFA, CHAYAT, MPATTE, CCARCASSONNE, YLEMERLE, J
- [22] MAINTENANCE CHEMOTHERAPY OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA .A. RELATION OF TOXICITY AND DRUG-DOSAGE TO RELAPSE-RISK .B. RELATION OF BONE-MARROW-TOXICITY AND HEPATO-TOXICITY TO RED BLOOD-CELL CONCENTRATION OF METHOTREXATE AND 6-THIOGUANINE NUCLEOTIDESMEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 388 - 388SCHMIEGELOW, KSCHRODER, HPULCZYNSKA, MHEJL, MBRUUNSHUUS, I
- [23] Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0–45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocolBMC Cancer, 22Linea Natalie ToksvangBodil Als-NielsenChristopher BaconRuta BertasiuteXimo DuarteGabriele EscherichElín Anna HelgadottirInga Rinvoll JohannsdottirÓlafur G. JónssonPiotr KozlowskiCecilia LangenskjöldKristi LepikRiitta NiinimäkiUlrik Malthe OvergaardMari PunabRiikka RätyHeidi SegersInge van der SluisOwen Patrick SmithMarion StrulluGoda VaitkevičienėHilde Skuterud WikMats HeymanKjeld Schmiegelow
- [24] Thiopurine Enhanced ALL Maintenance (TEAM): study protocol for a randomized study to evaluate the improvement in disease-free survival by adding very low dose 6-thioguanine to 6-mercaptopurine/methotrexate-based maintenance therapy in pediatric and adult patients (0-45 years) with newly diagnosed B-cell precursor or T-cell acute lymphoblastic leukemia treated according to the intermediate risk-high group of the ALLTogether1 protocolBMC CANCER, 2022, 22 (01)Toksvang, Linea NatalieAls-Nielsen, BodilBacon, ChristopherBertasiute, RutaDuarte, XimoEscherich, GabrieleHelgadottir, Elin AnnaJohannsdottir, Inga RinvollJonsson, Olafur G.Kozlowski, PiotrLangenskjold, CeciliaLepik, KristiNiinimaki, RiittaOvergaard, Ulrik MalthePunab, MariRaty, RiikkaSegers, Heidivan der Sluis, IngeSmith, Owen PatrickStrullu, MarionVaitkeviciene, GodaWik, Hilde SkuterudHeyman, MatsSchmiegelow, Kjeld